Meyka Pro banner
111, Inc.

111, Inc. Fundamental Analysis (NASDAQ: YI)

YI●NASDAQ
HealthcareMedical - Distribution
$3.45
$0.20(5.48%)
U.S. Market is Open · 10:54

111, Inc. Fundamental Analysis (NASDAQ: YI)

111, Inc. (NASDAQ: YI) shows moderate financial fundamentals with a PE ratio of -1.99, profit margin of -0.91%, and ROE of 23.64%. The company generates $10.3B in annual revenue with weak year-over-year growth of -15.19%.

Key Strengths

ROE23.64%
Cash Position1234.62%
PEG Ratio0.01

Areas of Concern

Operating Margin-0.48%
We analyze YI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.4/100

We analyze YI's fundamental strength across five key dimensions:

Efficiency Score

Weak

YI struggles to generate sufficient returns from assets.

ROA > 10%
-5.31%

Valuation Score

Excellent

YI trades at attractive valuation levels.

PE < 25
-1.99
PEG Ratio < 2
0.01

Growth Score

Weak

YI faces weak or negative growth trends.

Revenue Growth > 5%
-15.19%
EPS Growth > 10%
1.33%

Financial Health Score

Excellent

YI maintains a strong and stable balance sheet.

Debt/Equity < 1
-2.46
Current Ratio > 1
1.07

Profitability Score

Weak

YI struggles to sustain strong margins.

ROE > 15%
23.64%
Net Margin ≥ 15%
-0.91%
Positive Free Cash Flow
No

Key Financial Metrics

Is YI Expensive or Cheap?

P/E Ratio

YI trades at -1.99 times earnings. This suggests potential undervaluation.

-1.99

PEG Ratio

When adjusting for growth, YI's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values 111, Inc. at -1.83 times its book value. This may indicate undervaluation.

-1.83

EV/EBITDA

Enterprise value stands at -6.05 times EBITDA. This is generally considered low.

-6.05

How Well Does YI Make Money?

Net Profit Margin

For every $100 in sales, 111, Inc. keeps $-0.91 as profit after all expenses.

-0.91%

Operating Margin

Core operations generate -0.48 in profit for every $100 in revenue, before interest and taxes.

-0.48%

ROE

Management delivers $23.64 in profit for every $100 of shareholder equity.

23.64%

ROA

111, Inc. generates $-5.31 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.31%

Following the Money - Real Cash Generation

Operating Cash Flow

111, Inc. generates limited operating cash flow of $-34.86M, signaling weaker underlying cash strength.

$-34.86M

Free Cash Flow

111, Inc. generates weak or negative free cash flow of $-39.26M, restricting financial flexibility.

$-39.26M

FCF Per Share

Each share generates $-4.49 in free cash annually.

$-4.49

FCF Yield

YI converts -19.35% of its market value into free cash.

-19.35%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.99

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.008

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.46

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.07

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.24

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

-0.27

vs 25 benchmark

How YI Stacks Against Its Sector Peers

MetricYI ValueSector AveragePerformance
P/E Ratio-1.9930.63 Better (Cheaper)
ROE23.64%570.00% Weak
Net Margin-0.91%24326.00% Weak
Debt/Equity-2.460.52 Strong (Low Leverage)
Current Ratio1.075.69 Neutral
ROA-5.31%-59.00% (disorted) Weak

YI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 111, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

40.99%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

96.51%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

196.61%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ